Literature DB >> 21856420

Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells.

Kaizhong Duan1, Baojun Zhang, Wenying Zhang, Yunan Zhao, Yanyan Qu, Chenming Sun, Yong Zhao.   

Abstract

Regulatory T cells, especially CD4(+)CD25(+) regulatory T cells are critical regulators of immune tolerance in humans and mice. Mice with humanized immunity have been developed by various transplantation strategies of human tissues or cells related to immunity, which are being extensively applied in biomedical research. However, it is unclear whether human CD4(+)CD25(+) regulatory T cells can normally develop in human thymic grafts and efficiently populate in the periphery in NOD/SCID mouse recipients. In human thymic grafts, high percentage of mature human CD4(+)CD25(high) regulatory T cells was detected. Human CD4(+)CD25(+) regulatory T cells maturing in fetal human thymus grafts could subsequently output to the periphery of NOD/SCID mouse recipients. Importantly, these cells exhibited Foxp3(+)CD45RO(+)CTLA4(+)CD127(-) phenotype, similarly to those in healthy individuals. In addition, human CD4(+)CD25(+) regulatory T cells maturing in human thymic grafts suppressed proliferative response of CD4(+)CD25(-) T cells to allogeneic antigens, though the peripheral CD4(+)CD25(+) regulatory T cells in fetal human thymus-grafted NOD/SCID mice showed somewhat decreased immunosuppressive ability compared with normal CD4(+)CD25(+) regulatory T cells. Thus, this humanized animal model is suitable for examining development and function of human CD4(+)CD25(+) regulatory T cells in vivo.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856420     DOI: 10.1016/j.trim.2011.08.003

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  4 in total

Review 1.  Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells.

Authors:  Zheng Hu; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

2.  Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease.

Authors:  Jennifer L Lockridge; Ying Zhou; Yusof A Becker; Shidong Ma; Shannon C Kenney; Peiman Hematti; Christian M Capitini; William J Burlingham; Annette Gendron-Fitzpatrick; Jenny E Gumperz
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-24       Impact factor: 5.742

3.  Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Authors:  L Covassin; S Jangalwe; N Jouvet; J Laning; L Burzenski; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

4.  HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.

Authors:  Kei Sato; Naoko Misawa; Shingo Iwami; Yorifumi Satou; Masao Matsuoka; Yukihito Ishizaka; Mamoru Ito; Kazuyuki Aihara; Dong Sung An; Yoshio Koyanagi
Journal:  PLoS Pathog       Date:  2013-12-05       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.